A detailed history of Nfj Investment Group, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Nfj Investment Group, LLC holds 189,655 shares of IOVA stock, worth $1.42 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
189,655
Previous 198,430 4.42%
Holding current value
$1.42 Million
Previous $1.59 Million 11.88%
% of portfolio
0.05%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$7.28 - $11.9 $63,882 - $104,422
-8,775 Reduced 4.42%
189,655 $1.78 Million
Q2 2024

Aug 14, 2024

SELL
$7.78 - $14.19 $106,788 - $194,771
-13,726 Reduced 6.47%
198,430 $1.59 Million
Q1 2024

May 15, 2024

SELL
$7.59 - $17.47 $4,470 - $10,289
-589 Reduced 0.28%
212,156 $3.14 Million
Q4 2023

Feb 15, 2024

BUY
$3.3 - $8.89 $702,058 - $1.89 Million
212,745 New
212,745 $1.73 Million

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.18B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Nfj Investment Group, LLC Portfolio

Follow Nfj Investment Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nfj Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nfj Investment Group, LLC with notifications on news.